Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3; this appears to be a small metadata/UI update and does not affect study content.
    Difference
    0.2%
    Check dated 2026-01-14T01:39:36.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the page; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-23T08:37:39.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Minor system revision updating from v3.3.1 to v3.3.2, with no visible changes to study content, eligibility, or contact details.
    Difference
    0.2%
    Check dated 2025-12-01T16:55:21.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; the page now displays the new revision label and removes the previous one.
    Difference
    0.1%
    Check dated 2025-11-24T14:34:12.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The banner about the lapse in government funding and NIH operating status was removed.
    Difference
    0.4%
    Check dated 2025-11-17T06:54:43.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Core study details, eligibility criteria, and endpoints appear unchanged; only minor visual/layout adjustments were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-10T04:55:43.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.